Emcure launches Galact supplement for breastfeeding mothers in over-the-counter market
Emcure Pharmaceuticals has announced its foray into the over-the-counter (OTC) market with the launch of its flagship product, Galact. According to a press release, Galact, a lactation supplement designed to enhance breast milk production, has been prescribed by healthcare professionals for over two decades and will now be available as an OTC offering.
Tags
StockBeginner GuideAngel InvestingSME IPOEconomy MarketAIFInvestmentsMore
Stay Connected, Stay Informed –
Join Our
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn